150 related articles for article (PubMed ID: 30821698)
21. Breast cancer mortality after screening mammography in British Columbia women.
Coldman A; Phillips N; Warren L; Kan L
Int J Cancer; 2007 Mar; 120(5):1076-80. PubMed ID: 17149701
[TBL] [Abstract][Full Text] [Related]
22. The significance of combination chemotherapy in epithelial ovarian cancer.
Kwon JS; McGahan C; Dehaeck U; Santos J; Swenerton K; Carey MS
Int J Gynecol Cancer; 2014 Feb; 24(2):226-32. PubMed ID: 24401982
[TBL] [Abstract][Full Text] [Related]
23. Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada.
Tseng OL; Dawes MG; Spinelli JJ; Gotay CC; McBride ML
Osteoporos Int; 2017 Dec; 28(12):3439-3449. PubMed ID: 28993862
[TBL] [Abstract][Full Text] [Related]
24. Long-term Patterns of Excess Mortality among Endometrial Cancer Survivors.
Anderson C; Bae-Jump VL; Broaddus RR; Olshan AF; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1079-1088. PubMed ID: 33737298
[TBL] [Abstract][Full Text] [Related]
25. Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona.
Ameijide A; Clèries R; Carulla M; Buxó M; Marcos-Gragera R; Martínez JM; Vilardell ML; Vilardell M; Espinàs JA; Borràs JM; Izquierdo Á; Galceran J
Clin Transl Oncol; 2019 Aug; 21(8):1014-1025. PubMed ID: 30607790
[TBL] [Abstract][Full Text] [Related]
26. Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study.
Park J; Blackburn BE; Rowe K; Snyder J; Wan Y; Deshmukh V; Newman M; Fraser A; Smith K; Herget K; Burt L; Werner T; Gaffney DK; Lopez AM; Mooney K; Hashibe M
Ann Epidemiol; 2018 Jun; 28(6):377-384. PubMed ID: 29705053
[TBL] [Abstract][Full Text] [Related]
27. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
28. [State of health of populations residing in geothermal areas of Tuscany].
Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
[TBL] [Abstract][Full Text] [Related]
29. Causes of death after breast cancer diagnosis: A US population-based analysis.
Afifi AM; Saad AM; Al-Husseini MJ; Elmehrath AO; Northfelt DW; Sonbol MB
Cancer; 2020 Apr; 126(7):1559-1567. PubMed ID: 31840240
[TBL] [Abstract][Full Text] [Related]
30. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
Harding BN; Delaney JA; Urban RR; Weiss NS
Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
[TBL] [Abstract][Full Text] [Related]
31. Effect of age at diagnosis of breast cancer on the patterns and risk of mortality from all causes: a population-based study in Australia.
Beadle GF; McCarthy NJ; Baade PD
Asia Pac J Clin Oncol; 2013 Jun; 9(2):129-38. PubMed ID: 22898239
[TBL] [Abstract][Full Text] [Related]
32. Causes of death in long-term lung cancer survivors: a SEER database analysis.
Abdel-Rahman O
Curr Med Res Opin; 2017 Jul; 33(7):1343-1348. PubMed ID: 28426338
[TBL] [Abstract][Full Text] [Related]
33. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.
Kotsopoulos J; Rosen B; Fan I; Moody J; McLaughlin JR; Risch H; May T; Sun P; Narod SA
Gynecol Oncol; 2016 Jan; 140(1):42-7. PubMed ID: 26556769
[TBL] [Abstract][Full Text] [Related]
34. Impact of HIV infection and AIDS on death rates in British Columbia and Canada.
Hogg RS; Schechter MT; Montaner JS; Goldstone I; Craib K; O'Shaughnessy MV
CMAJ; 1994 Mar; 150(5):711-7. PubMed ID: 8313290
[TBL] [Abstract][Full Text] [Related]
35. Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992-2005: a population-based study.
Akhtar-Danesh N; Elit L; Lytwyn A
Gynecol Oncol; 2011 Nov; 123(2):192-5. PubMed ID: 21855119
[TBL] [Abstract][Full Text] [Related]
36. Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys.
Easton DF; Matthews FE; Ford D; Swerdlow AJ; Peto J
Int J Cancer; 1996 Jan; 65(3):284-94. PubMed ID: 8575846
[TBL] [Abstract][Full Text] [Related]
37. Secondary malignancies in long-term ovarian cancer survivors: results of the 'Carolin meets HANNA' study.
Woopen H; Rolf C; Braicu EI; Buttmann-Schweiger N; Barnes B; Baum J; Pietzner K; Kraywinkel K; Sehouli J
Int J Gynecol Cancer; 2021 May; 31(5):709-712. PubMed ID: 33649156
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
Son JH; Kong TW; Paek J; Song KH; Chang SJ; Ryu HS
Int J Gynaecol Obstet; 2017 Dec; 139(3):352-357. PubMed ID: 28857180
[TBL] [Abstract][Full Text] [Related]
39. Non-cancer mortality among long-term survivors of adult cancer in Korea: national cancer registry study.
Shin DW; Ahn E; Kim H; Park S; Kim YA; Yun YH
Cancer Causes Control; 2010 Jun; 21(6):919-29. PubMed ID: 20169405
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.
Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK
Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
